
raju karki
@rajukarki16
ID: 928314828
05-11-2012 20:10:52
59 Tweet
96 Followers
108 Following


Check out the latest from Balamurugan Sundaram, Nagakannan Pandian and team with Thirumala-Devi Kanneganti St. Jude Research, culminating a two decades-long search for NLRP12's trigger and downstream pathway! Out today Cell. Congrats to the team! ЁЯСП Thread ЁЯСЗ cell.com/cell/fulltext/тАж

A major congratulations to first authors Balamurugan Sundaram and Nagakannan Pandian and the team, Dr. Raghvendra Mall ЁЯЗоЁЯЗ│ЁЯЗзЁЯЗкЁЯЗ╢ЁЯЗжЁЯЗ║ЁЯЗ▓ЁЯЗжЁЯЗкЁЯСитАНЁЯТ╗, Yaqiu Wang, Roman Sarkar, Hee Jin Kim, Mrk Malireddi, raju karki, Laura Janke, Peter Vogel, and Thirumala-Devi Kanneganti, who dedicated countless hours to this project! ЁЯСПЁЯУ╖ЁЯСП


рджрдХреНрд╖рд┐рдг рднрд╛рд░рддреАрдп рдлрд┐рд▓реНрдо тАШрдЖрджрд┐рдкреБрд░реБрд╖тАЩрдорд╛ рд╕рдорд╛рд╡реЗрд╢ тАШрдЬрд╛рдирдХреА рднрд╛рд░рддреАрдп рдЫреЛрд░реА рд╣реБрдиреНтАЩ рднрдиреНрдиреЗ рд╕рдмреНрдж рдЬрдмрд╕рдореНрдо рдиреЗрдкрд╛рд▓рдорд╛ рдорд╛рддреНрд░ рдирднреИ рднрд╛рд░рддрдорд╛ рдкрдирд┐ рд╕рдЪреНрдЪрд┐рджреИрди рддрдм рд╕рдореНрдо рдХрд╛рдардорд╛рдбреМ рдорд╣рд╛рдирдЧрд░ рдкрд╛рд▓рд┐рдХрд╛ рднрд┐рддреНрд░ рдХреБрдиреИ рдкрдирд┐ рд╣рд┐рдиреНрджреА рдлрд┐рд▓реНрдо рдЪрд▓реНрди рджрд┐рдЗрдиреЗ рдЫреИрди ред рдпреЛ рд╕рдЪреНрдпрд╛рдЙрди рей рджрд┐рдирдХреЛ рд╕рдордп рджрд┐рдЗрдПрдХреЛ рдЫ ред рдорд╛рддрд╛ рд╕реАрддрд╛рдХреЛ рдЬрдп рд╣реЛрд╕ ред


It's finally out! Well-done to Dr. Amy Chan and many others from Inflammasome Lab! Caspase-4 dimerisation and D289 auto-processing elicit an interleukin-1╬▓-converting enzyme life-science-alliance.org/content/6/10/eтАж

Today Communications Biology: new work from first authors Mrk Malireddi and Ratnakar Bynigeri showing the utility of a #celldeath #CRISPR screen in innate #immune cells during #coronavirus infection to identify cell death molecules. Exciting #technique! St. Jude Research doi.org/10.1038/s42003тАж

Happening now: The inaugural CoE-III Symposium on innate immunity and #inflammation St. Jude Research with George Stark, Virginia Pascual, Dan Kastner, Judy Lieberman, Charles Dinarello @ProfPCDoherty Thirumala-Devi Kanneganti Prof. Hao Wu Schafer Lab. If you're on campus today, come to MTC!



If you are attending the Inflammasome #Therapeutics Summit today in #Boston, come discuss inflammasome targeting beyond NLRP3 with Thirumala-Devi Kanneganti in Workshop A (8-10:30 AM EST). Looking forward to an exciting presentation and discussions about other inflammasome targets!


Looking forward to seeing everyone at the Inflammasome #Therapeutics Summit. It's a perfect time for this meeting, as the translational & therapeutic potential of targeting #inflammasomes continues to grow. Thirumala-Devi Kanneganti will be presenting at 11:30 AM EST today. See you there!


Check out the new TrendsTalk series Trends in Molecular Medicine, where Thirumala-Devi Kanneganti shares insights into being a researcher in #Memphis, and other leaders talk about the experience in their regions. What a great way to learn about #science around the #world! authors.elsevier.com/a/1iPGX5Eb1BZkтАж


тнРтнРтнР Check out our new paper published in Science Advances on the DNA sensor Ku70 in preventing bowel cancer (1/5) science.org/doi/10.1126/scтАж


ЁЯдй Another fascinating role of the membrane disruptor protein NINJ1 in disease, revealed by the Kanneganti Lab. Check this out ЁЯСЗ

Kanneganti Lab Clarivate raju karki Congrats Thirumala-Devi Kanneganti Kanneganti Lab ! ЁЯШН Love it!


ЁЯШКDelighted to share our latest #publication in collab with Dr. Rajendra Karki & colleagues from Seoul National University. In this Nature Communications paper, we show that #acrolein, a byproduct of our cells but also found in #cigarette smoke, #kills cells & contributes to #inflammation ourANU 1/3
